CMSS1 antibody (AA 101-200) (Biotin)

Catalog No. ABIN1700223

This anti-CMSS1 antibody is a Rabbit Polyclonal antibody detecting CMSS1 in WB and ELISA. Suitable for Human.

Quick Overview for CMSS1 antibody (AA 101-200) (Biotin) (ABIN1700223)

Target: CMSS1 (Cms Small Ribosomal Subunit 1 (CMSS1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CMSS1 antibody is conjugated to Biotin

Application: Western Blotting (WB), ELISA

Product Details anti-CMSS1 Antibody (Biotin)

Binding Specificity: AA 101-200

Cross-Reactivity: Human

Predicted Reactivity: Mouse,Rat,Horse

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C3orf26

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for 12 months.

Expiry Date: 12 months

Target Details for CMSS1

Target: CMSS1 (Cms Small Ribosomal Subunit 1 (CMSS1))

Alternative Name: C3orf26

Background:

Synonyms: C3orf26, CC026_HUMAN, MGC4308, Uncharacterized protein C3orf26.

Background: Chromosome 3 is made up of about 214 million bases encoding over 1,100 genes. Notably, there is a chemokine receptor gene cluster and a variety of human cancer related loci on chromosome 3. Particular regions of the chromosome 3 short arm are deleted in many types of cancer cells. Key tumor suppressing genes on chromosome 3 encode apoptosis mediator RASSF1, cell migration regulator HYAL1 and angiogenesis suppressor SEMA3B. Marfan Syndrome, porphyria, von Hippel-Lindau syndrome, osteogenesis imperfecta and Charcot-Marie-Tooth Disease are a few of the numerous genetic diseases associated with chromosome 3. The C3orf26 gene product has been provisionally designated C3orf26 pending further characterization.